Canada boosts infectious disease preparedness with Winnipeg lab and BugSeq genomics tools

The Canadian federal government awarded a $10 million design contract to Winnipeg‑based Architecture49 Inc. for a $267 million medical countermeasures laboratory to be built beside the National Microbiology Laboratory in Winnipeg. The facility, slated for completion in 2033, will expand capacity to develop vaccines, treatments and diagnostic tools, reinforcing the city’s reputation as a global centre for infectious‑disease research. Winnipeg South MP Terry Duguid called the project “a big deal for our city, for our province, a big deal for life sciences in Canada.”

In parallel, Vancouver‑based biotech company BugSeq is advancing two genomics projects with support from Genome BC and Genome Canada. One project applies artificial‑intelligence analysis to predict antimicrobial‑resistance patterns, while the other uses pathogen‑agnostic metagenomic sequencing to detect known and novel respiratory threats. The tools are already deployed in public‑health laboratories across Canada, aiming to speed outbreak detection and enable more personalized antibiotic treatment.